339 related articles for article (PubMed ID: 29803661)
1. The role of the NLRP3 inflammasome and the activation of IL-1β in the pathogenesis of chronic viral hepatic inflammation.
Molyvdas A; Georgopoulou U; Lazaridis N; Hytiroglou P; Dimitriadis A; Foka P; Vassiliadis T; Loli G; Phillipidis A; Zebekakis P; Germenis AE; Speletas M; Germanidis G
Cytokine; 2018 Oct; 110():389-396. PubMed ID: 29803661
[TBL] [Abstract][Full Text] [Related]
2. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
[TBL] [Abstract][Full Text] [Related]
3. Differential Activation of NLRP3, AIM2, and IFI16 Inflammasomes in Humans with Acute and Chronic Hepatitis B.
Chen H; He G; Chen Y; Zhang X; Wu S
Viral Immunol; 2018 Nov; 31(9):639-645. PubMed ID: 30222506
[TBL] [Abstract][Full Text] [Related]
4. IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease.
Negash AA; Ramos HJ; Crochet N; Lau DT; Doehle B; Papic N; Delker DA; Jo J; Bertoletti A; Hagedorn CH; Gale M
PLoS Pathog; 2013; 9(4):e1003330. PubMed ID: 23633957
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
6. Development of tissue inflammation accompanied by NLRP3 inflammasome activation in rabbits infected with Treponema pallidum strain Nichols.
Lin LR; Xiao Y; Liu W; Chen YY; Zhu XZ; Gao ZX; Gao K; Tong ML; Zhang HL; Li SL; Lin HL; Li WD; Liang XM; Lin Y; Liu LL; Yang TC
BMC Infect Dis; 2018 Mar; 18(1):101. PubMed ID: 29490620
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients.
Zheng Q; Ren Y; Reinach PS; Xiao B; Lu H; Zhu Y; Qu J; Chen W
Exp Eye Res; 2015 May; 134():133-40. PubMed ID: 25701684
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitination and Activation of the NLRP3 Inflammasome by UCHL5 in HCV-Infected Cells.
Ramachandran A; Kumar B; Waris G; Everly D
Microbiol Spectr; 2021 Sep; 9(1):e0075521. PubMed ID: 34431717
[TBL] [Abstract][Full Text] [Related]
9. Fluorofenidone attenuates interleukin-1β production by interacting with NLRP3 inflammasome in unilateral ureteral obstruction.
Zheng L; Zhang J; Yuan X; Tang J; Qiu S; Peng Z; Yuan Q; Xie Y; Mei W; Tang Y; Meng J; Hu G; Tao L
Nephrology (Carlton); 2018 Jun; 23(6):573-584. PubMed ID: 28437591
[TBL] [Abstract][Full Text] [Related]
10. NLRP3 inflammasome and related cytokines reflect the immune status of patients with HBV-ACLF.
Jia Y; Ma L; Wang Y; Wang W; Shen C; Wang X; Xu H; Zhao C
Mol Immunol; 2020 Apr; 120():179-186. PubMed ID: 32169738
[TBL] [Abstract][Full Text] [Related]
11. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye.
Zheng Q; Ren Y; Reinach PS; She Y; Xiao B; Hua S; Qu J; Chen W
Exp Eye Res; 2014 Aug; 125():1-8. PubMed ID: 24836981
[TBL] [Abstract][Full Text] [Related]
13. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.
Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK
J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation.
Jiang S; Zhang Y; Zheng JH; Li X; Yao YL; Wu YL; Song SZ; Sun P; Nan JX; Lian LH
Pharmacol Res; 2017 Mar; 117():82-93. PubMed ID: 27940204
[TBL] [Abstract][Full Text] [Related]
15. Sendai Virus V Protein Inhibits the Secretion of Interleukin-1β by Preventing NLRP3 Inflammasome Assembly.
Komatsu T; Tanaka Y; Kitagawa Y; Koide N; Naiki Y; Morita N; Gotoh B; Yokochi T
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021903
[TBL] [Abstract][Full Text] [Related]
16. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
[TBL] [Abstract][Full Text] [Related]
18. Calcium-sensing receptor activates the NLRP3 inflammasome in LS14 preadipocytes mediated by ERK1/2 signaling.
D'Espessailles A; Mora YA; Fuentes C; Cifuentes M
J Cell Physiol; 2018 Aug; 233(8):6232-6240. PubMed ID: 29345311
[TBL] [Abstract][Full Text] [Related]
19. Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.
Pourcet B; Zecchin M; Ferri L; Beauchamp J; Sitaula S; Billon C; Delhaye S; Vanhoutte J; Mayeuf-Louchart A; Thorel Q; Haas JT; Eeckhoute J; Dombrowicz D; Duhem C; Boulinguiez A; Lancel S; Sebti Y; Burris TP; Staels B; Duez HM
Gastroenterology; 2018 Apr; 154(5):1449-1464.e20. PubMed ID: 29277561
[TBL] [Abstract][Full Text] [Related]
20. Activation of NLRP3 inflammasome in stable chronic obstructive pulmonary disease.
Markelić I; Hlapčić I; Čeri A; Radić Antolic M; Samaržija M; Popović-Grle S; Vukić Dugac A; Rumora L
Sci Rep; 2022 May; 12(1):7544. PubMed ID: 35534521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
